Brief: Elicera Therapeutics Receives EU Funding

Elicera Therapeutics AB

02/06/2022 07:41

June 2 (Reuters) - Elicera Therapeutics AB  ELIC.ST :
    * RECEIVES 2.5 MILLION EUROS IN EU FUNDING TO FULLY FINANCE
A
CLINICAL PHASE I/II-TRIAL WITH ITS CAR T-CELL THERAPY, ELC-301
    * GRANT IS SUFFICIENT TO FULLY FUND ELICERA'S PLANNED
CLINICAL
PHASE I/II-STUDY EVALUATING ITS CAR T-CELL THERAPY ELC-301 IN
TREATMENT OF B-CELL LYMPHOMA

Source text for Eikon:  ID:nWkrY3tpm 
Further company coverage:  ELIC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))